335 related articles for article (PubMed ID: 19358480)
1. Integrated PET/CT and cancer imaging.
De Wever W; Coolen J; Verschakelen JA
JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480
[TBL] [Abstract][Full Text] [Related]
2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
3. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
[TBL] [Abstract][Full Text] [Related]
4. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
5. Automatic arm removal in PET and CT images for deformable registration.
Gong L; Pathak S; Alessio A; Kinahan P
Comput Med Imaging Graph; 2006 Dec; 30(8):469-77. PubMed ID: 17084065
[TBL] [Abstract][Full Text] [Related]
6. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
Coleman RE; Delbeke D; Guiberteau MJ; Conti PS; Royal HD; Weinreb JC; Siegel BA; Federle MF; Townsend DW; Berland LL; ; ;
J Nucl Med; 2005 Jul; 46(7):1225-39. PubMed ID: 16000293
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography/computed tomography: protocol issues and options.
Blodgett TM; McCook BM; Federle MP
Semin Nucl Med; 2006 Apr; 36(2):157-68. PubMed ID: 16517237
[TBL] [Abstract][Full Text] [Related]
8. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer.
Kato H; Kimura H; Nakajima M; Sakai M; Sano A; Tanaka N; Inose T; Faried A; Saito K; Ieta K; Sohda M; Fukai Y; Miyazaki T; Masuda N; Fukuchi M; Ojima H; Tsukada K; Oriuchi N; Endo K; Kuwano H
Oncol Rep; 2008 Oct; 20(4):857-62. PubMed ID: 18813827
[TBL] [Abstract][Full Text] [Related]
9. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen.
Kuehl H; Veit P; Rosenbaum SJ; Bockisch A; Antoch G
J Nucl Med; 2007 Jan; 48 Suppl 1():45S-57S. PubMed ID: 17204720
[TBL] [Abstract][Full Text] [Related]
10. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
11. Multimodal imaging approaches: PET/CT and PET/MRI.
Pichler BJ; Judenhofer MS; Pfannenberg C
Handb Exp Pharmacol; 2008; (185 Pt 1):109-32. PubMed ID: 18626801
[TBL] [Abstract][Full Text] [Related]
12. Screening for cancer with PET and PET/CT: potential and limitations.
Schöder H; Gönen M
J Nucl Med; 2007 Jan; 48 Suppl 1():4S-18S. PubMed ID: 17204716
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
14. Molecular PET/CT imaging-guided radiation therapy treatment planning.
Zaidi H; Vees H; Wissmeyer M
Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
[TBL] [Abstract][Full Text] [Related]
15. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
Truong MT; Munden RF; Movsas B
J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
[TBL] [Abstract][Full Text] [Related]
16. Hybrid imaging (SPECT/CT and PET/CT)--improving the diagnostic accuracy of functional/metabolic and anatomic imaging.
Even-Sapir E; Keidar Z; Bar-Shalom R
Semin Nucl Med; 2009 Jul; 39(4):264-75. PubMed ID: 19497403
[TBL] [Abstract][Full Text] [Related]
17. Limitations of CT during PET/CT.
Gollub MJ; Hong R; Sarasohn DM; Akhurst T
J Nucl Med; 2007 Oct; 48(10):1583-91. PubMed ID: 17873133
[TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
19. Weight-based, low-dose pediatric whole-body PET/CT protocols.
Alessio AM; Kinahan PE; Manchanda V; Ghioni V; Aldape L; Parisi MT
J Nucl Med; 2009 Oct; 50(10):1570-7. PubMed ID: 19793734
[TBL] [Abstract][Full Text] [Related]
20. Application of PET/CT in the development of novel anticancer drugs.
Boss DS; Olmos RV; Sinaasappel M; Beijnen JH; Schellens JH
Oncologist; 2008 Jan; 13(1):25-38. PubMed ID: 18245010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]